Author:
Ben-Yosef R.,Sarid D.,Vexler A.,Lidawi G.,Barnea I.,Marmor S.,Stavesky A.,Starr A.,Hachoshen N. Yaal
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference22 articles.
1. Barton J, Blackledge G, Wakeling A et al (2001) Growth factors and their receptors: new targets for prostate cancer therapy. Urology 58:114–122
2. Di Lorenzo G, Tortora G, D’Armiento FP et al (2002) Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res 8:3438–3444
3. Gil-Diez de Medina S, Salomon L, Colombel M et al (1998) Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer. Hum Pathol 29:1005–1012
4. Moul JW, Maygarden SJ, Ware JL et al (1996) Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy. J Urol 155:982–985
5. Scher HI, Sarkis A, Reuter V et al (1995) Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin Cancer Res 1:545–550
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献